Users Stopping Slimming Jabs Regain Pounds at a Quadrupled Rate Than Dieters

A recent study suggests that patients who come off new slimming jabs like Wegovy and Mounjaro tend to recover shed pounds far faster than those who end conventional lifestyle regimens.

Findings released in a major health publication demonstrates that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping.

"Users buying these medications need to be informed of the danger of fast weight regain when the medication ends," stated researcher Dr. Susan Jebb.

This pace of regain means a reversion to pre-treatment mass within about a year and a half.

Comparing Treatments

The analysis, which looked at dozens of trials involving over 9,000 of participants, contrasted the outcomes of the injectable medications with older methods.

The team point out that individuals who shed pounds through diet and exercise typically have a slower weight regain—perhaps 0.1 kg a month—once they finish.

The Reason for the Rapid Rebound

Doctors believe the way of the drugs accounts for the heightened weight return.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.

"Long-term administration of the hormone concentrations far above than normal may cause the system to produce less of its own natural hormone, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.

"Stopping of this medication leads to hunger is no longer kept in check, making excessive eating much more probable."

An Ongoing Issue?

Health authorities recommend the jabs for individuals with weight-linked health risks, alongside recommended lifestyle changes.

A number of clinicians say that, due to the likelihood of relapse, the therapy might need to be ongoing.

This perspective is reinforced by pharmaceutical companies, who state that the findings "underscore the long-term nature of obesity," akin to managing conditions like hypertension.

Patient Testimonies

Individuals who have come off the medication report a intense return of cravings.

"I experienced something activating and you become starving," said an individual.

This difficulty is worsened if patients have not established lasting dietary or behavioural changes during treatment.

Growing Use

Recent estimates suggest that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.

• Adoption is higher among women than men.
• The 40s and 50s age group shows the highest level of interest.
• Many access the drugs through private prescriptions rather than public health services.

In conclusion, clinicians emphasize that while these medications are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits likely depends on combined lifestyle management.